-- 根據上海證券交易所發布的招股說明書顯示，鋯及特種尼龍產品供應商昌宇控股（SHA:603407）已向上海證券交易所提交首次公開募股（IPO）申請，擬發行4,100萬股股票。 募款將用於公司旗下氯氧化鋯及深層加工專案、尼龍彈性體產品專案以及生物陶瓷和功能陶瓷產品專案。 西南證券擔任此次IPO的主承銷商。
Related Articles
Asia
New Zealand Shares End Slightly Higher Amid Rising Middle East Tensions; Channel Infrastructure Secures Deal to Expand Diesel Storage at Marsden Point
New Zealand shares ended marginally higher on Monday after tensions rose in the Middle East, as the end of the two-week US-Iran ceasefire draws near.The S&P/NZX 50 Index edged up 0.1% or 9.8 points to close at 12,915.45.Tensions rose in the Middle East as the US seized an Iranian cargo ship and Iran's top military command vowed to retaliate. US President Donald Trump said he was sending envoys for talks in Pakistan. However, Iran rejected new peace talks with the US, its state news agency reported.Trump said he would launch new strikes on Iran if it didn't agree to his terms.In domestic news, New Zealand recorded a goods trade surplus of NZ$698 million in March, compared with a deficit of NZ$364.7 million in February, Stats NZ data showed. Goods exports rose 7.3% to NZ$7.94 billion, while imports rose 9.6% to NZ$7.25 billion..New Zealand's first-quarter consumer price index is anticipated to rise by 0.8% quarter on quarter and 2.9% year on year, which is slightly below the Reserve Bank of New Zealand's revised April forecast of 3%, brokerage firm BofA Securities said.In corporate news, Channel Infrastructure (NZE:CHI, ASX:CHI) confirmed an agreement with the New Zealand Government to add 93 million liters of diesel storage at its Marsden Point Energy Precinct, equivalent to around nine more days of national diesel demand.Genesis Energy (NZE:GNE, ASX:GNE) reached a final investment decision on the second stage of its battery energy storage system program at Huntly Power Station on New Zealand's North Island, with an estimated project cost of about NZ$106 million.Lastly, Fletcher Building (NZE:FBU, ASX:FBU) said the planned sale of Fletcher Construction to Vinci Construction has cleared key regulatory approvals in New Zealand, including Overseas Investment Office consent and confirmation from the Commerce Commission that it will not further review the transaction.
$^NZ50$ASX:CHI$ASX:FBU$ASX:GNE$NZE:CHI$NZE:FBU$NZE:GNE
Asia
Zhenyuan's Deputy General Manager Placed in Detention
Zhejiang Zhenyuan's (SHE:000705) deputy general manager, Wei Min, was placed in detention for investigation, according to a Shenzhen bourse filing on Saturday.The pharmaceutical wholesale company did not disclose the reason for the detention but said its production and operations remain unaffected over the matter.The company's shares fell 2% during the afternoon trade.
$SHE:000705
Asia
Salubris Pharmaceuticals' Subsidiary Presents Positive Effects of JK06 At American Association for Cancer Research
Shenzhen Salubris Pharmaceuticals' (SHE:002294) subsidiary, Salubris Biotherapeutics, presented the positive effects of the JK06 at the American Association for Cancer Research, according to a Shenzhen bourse filing on Monday.The drug was tested for metastatic tumors, including non-small cell lung cancer and breast cancer, in phases 1/2 clinical trials.The drug showed good safety and efficacy in patients during the trials.The pharmaceutical company's shares dropped 4% during the afternoon trade.
$SHE:002294